MedPlus's parent set the buyback limit, not the group
MedPlus's accounts at 31 March 2026, the parent company alone and the whole group, in ₹ crore. The lower, the parent's, caps a buyback the board can approve without a shareholder vote.
MedPlus's parent set the buyback limit, not the group
MedPlus's accounts at 31 March 2026, the parent company alone and the whole group, in ₹ crore. The lower, the parent's, caps a buyback the board can approve without a shareholder vote.
₹ CRORE
Parent company aloneWhole group
The board approved ₹130 crore, 98.7% of this limit
The limit is 10% of paid-up capital and free reserves, on whichever accounts give the lower figure. Above it, shareholders must vote.
MedPlus Health Services, BSE filing of 10 November 2026: public announcement for the buyback, section 6 · 31 Mar 2026
Share it
The numbers
Embed it on your site
The code carries a credit line that links back to this page. Keep it with the chart.
From the insight
MedPlus's ₹130 crore buyback rests on share premium, not profit